Related Experiment Video
Updated: Jul 7, 2026
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Profiling essential genes in human mammary cells by multiplex RNAi screening
Jose M Silva1, Krista Marran, Joel S Parker
1Watson School of Biological Sciences, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Abstract:
By virtue of their accumulated genetic alterations, tumor cells may acquire vulnerabilities that create opportunities for therapeutic intervention. We have devised a massively parallel strategy for screening short hairpin RNA (shRNA) collections for stable loss-of-function phenotypes. We assayed from 6000 to 20,000 shRNAs simultaneously to identify genes important for the proliferation and survival of five cell lines derived from human mammary tissue. Lethal shRNAs common to these cell lines targeted many known cell-cycle regulatory networks. Cell line-specific sensitivities to suppression of protein complexes and biological pathways also emerged, and these could be validated by RNA interference (RNAi) and pharmacologically. These studies establish a practical platform for genome-scale screening of complex phenotypes in mammalian cells and demonstrate that RNAi can be used to expose genotype-specific sensitivities.
Insights
Researchers screened thousands of short hairpin RNAs (shRNAs) to find vulnerabilities in human breast cancer cells. This approach identified key genes for cell survival and revealed specific weaknesses exploitable for targeted therapies.
Area of Science:
- Genomics
- Molecular Biology
- Cancer Research
Background:
- Tumor cells accumulate genetic alterations, leading to vulnerabilities exploitable for therapeutic intervention.
- Identifying these vulnerabilities is crucial for developing effective cancer treatments.
Purpose of the Study:
- To develop a massively parallel screening strategy for identifying genes essential for cancer cell proliferation and survival.
- To uncover both common and cell line-specific genetic vulnerabilities in human mammary tumor cells.
Main Methods:
- Simultaneously screened 6,000 to 20,000 short hairpin RNAs (shRNAs) in five human mammary cell lines.
- Assayed for stable loss-of-function phenotypes to identify essential genes.
- Validated cell line-specific sensitivities using RNA interference (RNAi) and pharmacological agents.
Main Results:
- Identified numerous genes critical for proliferation and survival across multiple cell lines, many involved in cell-cycle regulation.
- Discovered cell line-specific sensitivities to the suppression of protein complexes and biological pathways.
- Validated these genotype-specific sensitivities through RNA interference and drug treatments.
Conclusions:
- Established a practical platform for genome-scale screening of complex phenotypes in mammalian cells.
- Demonstrated that RNA interference (RNAi) can effectively expose genotype-specific cancer vulnerabilities.
- This approach offers a powerful tool for identifying novel therapeutic targets in cancer.
